Ferring Debuts Gene Therapy Manufacturing Facility in Parsippany
Ferring Pharmaceutical, a global life sciences company specializing in reproductive medicine, uro-oncology and specialty areas within orthopaedics, and gastroenterology, including microbiome therapeutics, held a ribbon-cutting ceremony yesterday for its new 12,000-square-foot gene therapy manufacturing facility located within its US headquarters in Parsippany. The new facility is producing ADSTILADRIN, the first and only FDA-approved gene therapy delivered directly to the bladder for…
“Fusce volutpat – diam sapien, non cons ectetu aliquam ornare sapien, a suscipit nisi!”
